Luteolin potentiates antibiotic activity against multidrug-resistant Pseudomonas aeruginosa and modulates efflux-associated resistance and biofilm-associated phenotypes
Abstract
Multidrug-resistant Pseudomonas aeruginosa is a WHO critical-priority pathogen whose recalcitrance is driven largely by efflux pump overexpression and biofilm formation, two mechanisms rarely addressed by a single agent. Here we evaluated whether luteolin, a plant-derived flavone, could potentiate conventional antibiotics and suppress biofilm-associated phenotypes in multidrug-resistant P. aeruginosa . Checkerboard assays against PAO1 and 20 multidrug-resistant clinical isolates revealed predominantly additive interactions with no antagonism: luteolin–ceftazidime combinations were additive in 16 of 21 strains (indifferent in 5), and luteolin–ciprofloxacin combinations were additive in 18 of 21 strains (indifferent in 3); luteolin reduced the ceftazidime and ciprofloxacin MICs by 2- to 8-fold across the entire panel. At sub-inhibitory concentrations, luteolin inhibited biofilm formation by up to 71%, disrupted pre-established mature biofilms, reduced extracellular polysaccharide and DNA content, and suppressed swimming and swarming motility in a concentration-dependent manner; these anti-biofilm effects were further enhanced by combination with either antibiotic. Functional assays showed increased intracellular ethidium bromide retention, accompanied by transcriptional downregulation of efflux, biofilm-matrix, quorum-sensing, and flagellar genes. Luteolin also modestly increased outer membrane permeability while producing limited effects on inner membrane integrity, suggesting that both efflux-associated and membrane-related effects may contribute to its antibiotic-potentiating activity. Molecular docking suggested that luteolin may occupy a binding pocket within the MexB transporter, providing a plausible structural hypothesis pending experimental confirmation. In cell culture and an invertebrate infection model, luteolin exhibited low cytotoxicity, reduced macrophage injury during infection, and its combination with ceftazidime markedly improved larval survival in a Galleria mellonella infection model, suggesting that luteolin warrants further preclinical investigation as a multi-target antibiotic adjuvant candidate against multidrug-resistant P. aeruginosa .
Related
- Pseudomonas aeruginosa modulates Staphylococcus aureus biofilm formation and antibiotic resistance
- Molecular and genomic characterization of biofilm associated antimicrobial resistance in clinical and resistant isolates of Pseudomonas aeruginosa in Iraq
- D-enantiomeric β-casein 197 disrupts biofilm-associated infection of MDR Pseudomonas aeruginosa and Acinetobacter baumannii through superior LPS binding and host cell protection
- Expression of ExsA in trans Confers Type III Secretion System-Dependent Cytotoxicity on Noncytotoxic Pseudomonas aeruginosa Cystic Fibrosis Isolates
- Role of manganese superoxide dismutase in a mucoid isolate of Pseudomonas aeruginosa: adaptation to oxidative stress
BibTeX
@article{he2026luteolin,
title = {{Luteolin potentiates antibiotic activity against multidrug-resistant Pseudomonas aeruginosa and modulates efflux-associated resistance and biofilm-associated phenotypes}},
author = {Wei He and Kaichong Jiang and Tianhao Wang and Yinong Huang},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73711-4},
url = {https://www.nature.com/articles/s41598-026-73711-4},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Luteolin potentiates antibiotic activity against multidrug-resistant Pseudomonas aeruginosa and modulates efflux-associated resistance and biofilm-associated phenotypes
AU - Wei He
AU - Kaichong Jiang
AU - Tianhao Wang
AU - Yinong Huang
PY - 2026
DA - 2026/10/07
JO - Scientific Reports
DO - 10.1038/s41598-026-73711-4
UR - https://www.nature.com/articles/s41598-026-73711-4
AB - Multidrug-resistant Pseudomonas aeruginosa is a WHO critical-priority pathogen whose recalcitrance is driven largely by efflux pump overexpression and biofilm formation, two mechanisms rarely addressed by a single agent. Here we evaluated whether luteolin, a plant-derived flavone, could potentiate conventional antibiotics and suppress biofilm-associated phenotypes in multidrug-resistant P. aeruginosa . Checkerboard assays against PAO1 and 20 multidrug-resistant clinical isolates revealed predominantly additive interactions with no antagonism: luteolin–ceftazidime combinations were additive in 16 of 21 strains (indifferent in 5), and luteolin–ciprofloxacin combinations were additive in 18 of 21 strains (indifferent in 3); luteolin reduced the ceftazidime and ciprofloxacin MICs by 2- to 8-fold across the entire panel. At sub-inhibitory concentrations, luteolin inhibited biofilm formation by up to 71%, disrupted pre-established mature biofilms, reduced extracellular polysaccharide and DNA content, and suppressed swimming and swarming motility in a concentration-dependent manner; these anti-biofilm effects were further enhanced by combination with either antibiotic. Functional assays showed increased intracellular ethidium bromide retention, accompanied by transcriptional downregulation of efflux, biofilm-matrix, quorum-sensing, and flagellar genes. Luteolin also modestly increased outer membrane permeability while producing limited effects on inner membrane integrity, suggesting that both efflux-associated and membrane-related effects may contribute to its antibiotic-potentiating activity. Molecular docking suggested that luteolin may occupy a binding pocket within the MexB transporter, providing a plausible structural hypothesis pending experimental confirmation. In cell culture and an invertebrate infection model, luteolin exhibited low cytotoxicity, reduced macrophage injury during infection, and its combination with ceftazidime markedly improved larval survival in a Galleria mellonella infection model, suggesting that luteolin warrants further preclinical investigation as a multi-target antibiotic adjuvant candidate against multidrug-resistant P. aeruginosa .
SN - 2045-2322
ER -